<html>
<head>PUBMED IDs for VKORC1</head>
<body bgcolor='#C5F0F2'><h1>VKORC1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14765194/'>Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.</a> February 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15358623/'>A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.</a> September 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15630486/'>Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.</a> January 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15790782/'>Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.</a> March 26  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15879509/'>The genetic basis of resistance to anticoagulants in rodents.</a> May 10  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15888487/'>A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.</a> May 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15930419/'>Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.</a> June 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15947090/'>The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.</a> June 11  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15978113/'>A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance.</a> June 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16201835/'>A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk.</a> October 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16268497/'>Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.</a> November 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16270629/'>VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation.</a> November 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16420583/'>Population variation in VKORC1 haplotype structure.</a> January 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16432637/'>Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients.</a> January 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16513444/'>Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population.</a> March 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16549638/'>VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection).</a> March 22  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16611750/'>Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation.</a> April 14  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16611310/'>The c.-1639G &gt; A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients.</a> April 14  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16634640/'>r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.</a> April 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16637447/'>[Pharmacogenetics of warfarin].</a> April 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16637386/'>[Predictive factors in esophageal cancer after neoadjuvant therapy].</a> April 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16637315/'>[Expression of human papilloma virus (HPV) and P16ink4a in cervical intraepithelial neoplasia (CIN) and papilloma].</a> April 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16676068/'>The influence of sequence variations in factor VII, gamma-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement.</a> May 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16677080/'>Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.</a> May 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16700826/'>Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C&gt;T in a Chinese and a Caucasian population.</a> May 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16720838/'>Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency.</a> May 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16847429/'>APOE genotype makes a small contribution to warfarin dose requirements.</a> July 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16869821/'>A case study of acenocoumarol sensitivity and genotype-phenotype discordancy explained by combinations of polymorphisms in VKORC1 and CYP2C9.</a> July 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16879214/'>Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records.</a> August 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16883270/'>[Pharmacogenetics of indirect anticoagulants: value of genotype for improvement of efficacy and safety of therapy].</a> August 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16890578/'>VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.</a> August 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16960144/'>The pharmocogenomics of warfarin: closing in on personalized medicine.</a> September 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16983400/'>Pharmacogenetics of warfarin: current status and future challenges.</a> September 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17048007/'>Association of warfarin dose with genes involved in its action and metabolism.</a> October 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17049586/'>Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.</a> October 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17110937/'>Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity.</a> November 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17110920/'>A novel mutation in GJA8 associated with autosomal dominant congenital cataract in a family of Indian origin.</a> November 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17110919/'>The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients.</a> November 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17110918/'>Fenretinide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells is associated with the differential expression of Hsp70, 14-3-3, pax-6, tubulin beta-III, NSE, and bag-1 proteins.</a> November 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17161452/'>Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.</a> December 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17189218/'>Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population.</a> December 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17192772/'>VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement.</a> December 29  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17325732/'>Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans.</a> February 28  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17329985/'>Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians.</a> March 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17387222/'>Genetic-based dosing in orthopedic patients beginning warfarin therapy.</a> March 28  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17496169/'>Building individualized medicine: prevention of adverse reactions to warfarin therapy.</a> May 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17510308/'>Estimation of warfarin maintenance dose based on VKORC1 (-1639 G&gt;A) and CYP2C9 genotypes.</a> May 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17549303/'>Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans.</a> June 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17611042/'>[Impact of pharmacogenetics on interindividual variability in the response to vitamin K antagonist therapy].</a> July 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17611041/'>Differential display fingerprints: new approach to characterize smooth muscle cells and human coronary atherectomy tissues.</a> July 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17661181/'>Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing.</a> July 31  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17661172/'>Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques.</a> July 31  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17666014/'>VKORC1 gene variation and venous thrombosis: 'another one bites the dust'?</a> August 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17721328/'>CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s).</a> August 28  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17849045/'>Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.</a> September 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17883699/'>Common VKORC1 variants are not associated with arterial or venous thrombosis.</a> September 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17955831/'>[Oral anticoagulation and pharmacogenetics: importance in the clinical setting].</a> October 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17995970/'>Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients.</a> November 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18030307/'>Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patients.</a> November 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18034619/'>Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.</a> November 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18177690/'>Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection.</a> January 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18183038/'>Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes.</a> January 10  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18218987/'>Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study.</a> January 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18224312/'>Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.</a> January 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18224285/'>Expression profiles of cytokines and chemokines in murine MDR1a-/- colitis.</a> January 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18234403/'>Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.</a> February 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18240904/'>Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients.</a> February 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18252229/'>Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.</a> February 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18281922/'>Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin.</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18281915/'>A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18278162/'>[New insight in therapeutic anticoagulation by Coumarin derivatives].</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18278133/'>[Interleukin-1 family polymorphisms in aggressive periodontitis patients and their relatives].</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18278130/'>[PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome].</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18315553/'>Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency.</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18362220/'>VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals.</a> March 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18370846/'>Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.</a> March 29  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18374198/'>Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.</a> April 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18374188/'>VKORC1 and the vitamin K cycle.</a> April 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18419745/'>A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon.</a> April 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18449434/'>No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease.</a> May 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18464049/'>Pharmacogenomics of 4-hydroxycoumarin anticoagulants.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18523153/'>Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.</a> June 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18532998/'>Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans.</a> June 6  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18535201/'>A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.</a> June 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18535191/'>Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.</a> June 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18542936/'>VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.</a> June 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18574025/'>The largest prospective warfarin-treated cohort supports genetic forecasting.</a> June 25  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18629445/'>Dependency of phenprocoumon dosage on polymorphisms in the VKORC1 and CYP2C9 genes.</a> July 17  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18690851/'>Warfarin dosing and the promise of pharmacogenomics.</a> August 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18698879/'>Pharmacogenetics of oral anticoagulants: a basis for dose individualization.</a> August 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18752379/'>Warfarin pharmacogenetics.</a> August 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18763667/'>Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report.</a> September 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18763633/'>[Interaction of the polymorphism of vitamin D receptor gene start codon with physical activity on bone mass accrual in Chinese adolescent girls].</a> September 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18763594/'>[PCR definition of B-cell clonality: which electrophoretic method is better].</a> September 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18763589/'>[Efficacy of conservative treatment of gastric lymphosarcoma].</a> September 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18776969/'>Warfarin resistance.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18776959/'>Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18776955/'>Two novel myocilin mutations in a Chinese family with primary open-angle glaucoma.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18776953/'>Molecular analysis of the PAX6 gene in Mexican patients with congenital aniridia: report of four novel mutations.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18776951/'>Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18776948/'>HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells.</a> September 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18781859/'>Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics.</a> September 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18781852/'>Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy.</a> September 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18805772/'>[Haplogroup analysis of vitamin-K epoxide reductase (VKORC1) gene: novel element in the optimization of anticoagulant therapy].</a> September 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18826394/'>Lack of association between variants in the VKORC1 gene and cerebrovascular or coronary heart disease.</a> October 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18841283/'>Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population.</a> October 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18998206/'>Understanding the pharmacogenetic approach to warfarin dosing.</a> November 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18998201/'>Sonoporation of the minicircle-VEGF(165) for wound healing of diabetic mice.</a> November 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19018719/'>VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients.</a> November 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19018718/'>VKORC1 polymorphisms in Amerindian populations of Brazil.</a> November 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19018716/'>Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype.</a> November 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025725/'>The association between dietary vitamin K intake and serum undercarboxylated osteocalcin is modulated by vitamin K epoxide reductase genotype.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025652/'>A functional Notch-survivin gene signature in basal breast cancer.</a> April 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025648/'>Dynamical modeling of the cholesterol regulatory pathway with Boolean networks.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025644/'>Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025642/'>Genome adaptation to chemical stress: clues from comparative transcriptomics in Saccharomyces cerevisiae and Candida glabrata.</a> February 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025640/'>Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025632/'>Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025627/'>The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025616/'>ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025611/'>Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025601/'>Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19025599/'>Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19116367/'>Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene.</a> February 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19117406/'>SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.</a> March 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19124480/'>Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition.</a> March 4  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19124474/'>Microarrays and epidemiology: ensuring the impact and accessibility of research findings.</a> March 4  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19116367/'>Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene.</a> February 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19135231/'>Effect of VKORC1-1639 G&gt;A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients.</a> September 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19179293/'>A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity.</a> March 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19181737/'>Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2.</a> April 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19200363/'>Novel mutations in the VKORC1 gene of wild rats and mice--a response to 50 years of selection pressure by warfarin?</a> March 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19225451/'>Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period.</a> April 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19228012/'>Spatial DNA melting analysis for genotyping and variant scanning.</a> September 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19233910/'>A multiplex assay for detecting genetic variations in CYP2C9, VKORC1, and GGCX involved in warfarin metabolism.</a> April 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19270263/'>Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy.</a> June 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19297519/'>CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.</a> June 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19300499/'>A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.</a> May 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19324988/'>Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.</a> June 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19397481/'>Pharmacogenetics of vitamin K antagonists: useful or hype?</a> August 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19436136/'>Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status.</a> July 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19479657/'>Warfarin pharmacogenomics.</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19479655/'>Nevirapine hypersensitivity reaction: will the real HLA please stand up?</a> July 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19540002/'>Genetic and clinical factors relating to warfarin dosing.</a> August 4  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19567378/'>Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate.</a> March 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19578179/'>A genome-wide association study of acenocoumarol maintenance dosage.</a> November 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19578166/'>First locus for primary pulmonary vein stenosis maps to chromosome 2q.</a> December 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19598072/'>Vitamin K-dependent coagulation factors deficiency.</a> September 12  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19662888/'>[Application of warfarin pharmacogenetics].</a> September 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19686083/'>Pharmacogenetics of warfarin.</a> May 7  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19745563/'>VKORC1 diplotype-derived dosing model to explain variability in warfarin dose requirements in Asian patients.</a> January 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19780415/'>[The c.-1639g &gt; A polymorphism of the VKORC1 gene and his influence on the therapeutic response during oral anticoagulants use].</a> October 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19794411/'>Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients.</a> January 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19842934/'>VKORC1 haplotypes in five East-Asian populations and Indians.</a> April 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19857286/'>[Resistance to coumarin derivatives due to mutated vitamin-K enzyme].</a> February 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19857283/'>[Dutch patients with hereditary pancreatitis; high mutation frequency, relatively little pain].</a> February 5  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19875892/'>A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G&gt;A) and interindividual variability in the dose-effect of vitamin K antagonists.</a> March 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19882083/'>Pharmacogenetic polymorphisms in Brazilian-born, first-generation Japanese descendants.</a> September 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19882051/'>Bile acid transport correlative protein mRNA expression profile in human placenta with intrahepatic cholestasis of pregnancy.</a> January 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19942260/'>Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement--a systematic review and meta analysis.</a> July 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20017677/'>ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese.</a> March 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22134997/'>[Optimalisation of treatment with vitamin K antagonists--the role of gene polymorphisms].</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20043560/'>Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in northern Thailand.</a> January 12  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22134997/'>[Optimalisation of treatment with vitamin K antagonists--the role of gene polymorphisms].</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20072124/'>Genetic and clinical predictors of warfarin dose requirements in African Americans.</a> April 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20073138/'>Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.</a> March 12  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082485/'>Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082483/'>NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082482/'>Immunogenetic characteristics of patients with autoimmune gastritis.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082479/'>Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082478/'>Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082477/'>Helicobacter pylori HopE and HopV porins present scarce expression among clinical isolates.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082476/'>Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.</a> April 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20101557/'>[Pharmacogenomics in routine medical care].</a> February 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20101521/'>Selective IgA deficiency.</a> June 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20121287/'>Variant VKORC1 and CYP2C9 alleles in patients with diffuse alveolar hemorrhage caused by oral anticoagulants.</a> April 27  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20163834/'>The VKORC1 promoter is occupied by c-Myc transcription factor in HepG2 cells.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20193673/'>Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20200517/'>A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.</a> April 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20205664/'>Pharmacogenetics of oral anticoagulant therapy.</a> July 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20210733/'>Distribution of CYP2C9 and VKORC1 risk alleles for warfarin sensitivity and resistance in the Israeli population.</a> October 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20226775/'>Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping.</a> August 31  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20339978/'>The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements in an adult Turkish population.</a> June 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20339950/'>FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer.</a> December 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20350128/'>Pharmacogenetics of coumarinic oral anticoagulants.</a> June 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20354686/'>Increased frequency of CYP2C9 variant alleles and homozygous VKORC1*2B carriers in warfarin-treated patients with excessive INR response.</a> July 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20375999/'>Integration of genetic, clinical, and INR data to refine warfarin dosing.</a> May 4  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20386359/'>Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.</a> September 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20386089/'>Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation.</a> June 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20393654/'>End-capped HyBeacon probes for the analysis of human genetic polymorphisms related to warfarin metabolism.</a> October 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20402581/'>Role of warfarin pharmacogenetic testing in clinical practice.</a> June 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20415550/'>MicroRNAs and pharmacogenomics.</a> July 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20499136/'>An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.</a> February 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20504253/'>Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.</a> October 20  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20532885/'>Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders.</a> October 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20555338/'>Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements.</a> February 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20581661/'>The c.-1639G&gt;A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy.</a> March 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20581655/'>The interaction of ACP1, ADA1, diabetes and gender in coronary artery disease.</a> August 31  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20579077/'>Novel VKORC1 mutations associated with warfarin sensitivity.</a> November 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20585445/'>A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants.</a> January 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20615525/'>VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.</a> December 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20621035/'>Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.</a> August 4  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20653676/'>CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.</a> January 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20653674/'>A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients.</a> January 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20653608/'>Myogenic and proteolytic mRNA expression following blood flow restricted exercise.</a> May 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20653606/'>The brain-derived neutrophic factor val66met polymorphism and sudden unexpected infant death.</a> April 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20653589/'>Use of quantitative broad-based polymerase chain reaction for detection and identification of common bacterial pathogens in cerebrospinal fluid.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20688006/'>[Warfarin hipersensitivity: how to deal with it?].</a> November 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20811787/'>The association of protein S Tokushima-K196E with a risk of deep vein thrombosis.</a> December 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20833980/'>In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes.</a> February 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20833655/'>Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese.</a> May 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20842355/'>VKORC1-1639G&gt;A, CYP2C9, EPHX1691A&gt;G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China.</a> March 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20889555/'>Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.</a> March 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20885015/'>Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran.</a> January 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20946155/'>Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21057703/'>Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy.</a> May 19  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21057694/'>Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.</a> June 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21063236/'>Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes.</a> April 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21084764/'>Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients.</a> October 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21103663/'>Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation.</a> June 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21103634/'>Placental stem cell differentiation into islets of Langerhans-like glucagon-secreting cells.</a> April 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21103627/'>Prognostic and predictive significance of the bcl-2/IgH translocation in malignant follicular lymphomas.</a> April 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21110192/'>Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.</a> July 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21127708/'>Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction.</a> March 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21179439/'>VKORC1 common variation and bone mineral density in the Third National Health and Nutrition Examination Survey.</a> July 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21179430/'>Missense mutations at homologous positions in the fourth and fifth laminin A G-like domains of eyes shut homolog cause autosomal recessive retinitis pigmentosa.</a> February 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21179429/'>Physiological expression of lens α-, β-, and γ-crystallins in murine and human corneas.</a> February 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21179427/'>CyclinD1 protein expressed in pterygia is associated with β-catenin protein localization.</a> February 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21176721/'>Contribution of 1173C &gt; T polymorphism in the VKORC1 gene to warfarin dose requirements in Han Chinese patients receiving anticoagulation.</a> February 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21215088/'>[Gene polymorphism of CYP450 2C9 and VKORC1 in Chinese population and their relationships to the maintaining dosage of warfarin].</a> March 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21248432/'>Frequencies of VKORC1 -1639 G&gt;A, CYP2C9*2 and CYP2C9*3 genetic variants in the Northern Indian population.</a> April 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21248368/'>Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.</a> April 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21261182/'>Exposure to non-therapeutic INR in a high risk cardiovascular patient: potential hazard reduction with genotype-guided warfarin (Coumadin) dosing.</a> February 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21261120/'>[Birth weight and genetic risk of type 2 diabetes in Czech population].</a> May 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21270790/'>The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.</a> April 5  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21321468/'>Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin.</a> April 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21326313/'>Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.</a> August 23  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21386709/'>Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.</a> April 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21412232/'>Pharmacogenetics: from bench to byte--an update of guidelines.</a> June 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21451434/'>Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient.</a> August 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21453274/'>Clinical applicability of sequence variations in genes related to drug metabolism.</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21544933/'>[CYP2C9 and VKORC1 gene polymorphism and acenocoumarol anticoagulant activity in Russian patients at high risk of thromboembolic complications].</a> July 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21545618/'>Modelling the atypical absorption of menatetrenone and the metabolism to its epoxide: effect of VKORC1 polymorphism.</a> September 3  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21562147/'>Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.</a> December 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21562135/'>Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses.</a> March 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21590310/'>Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.</a> February 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21635147/'>Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21651319/'>Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population.</a> March 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21681008/'>The influence of CYP2C9 and VKORC1 gene polymorphisms on optimal warfarin doses after heart valve replacement.</a> December 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21692610/'>Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians.</a> June 23  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21713378/'>Pharmacogenetic distribution of warfarin and its clinical significance in Korean patients during initial anticoagulation therapy.</a> March 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21725053/'>Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21767890/'>Association of VKORC1 -1639 G&gt;A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus.</a> March 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21786578/'>[Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].</a> August 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21800014/'>Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis.</a> January 11  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21815482/'>[Possible application of pharmacogenomics to warfarin therapy].</a> October 26  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21827742/'>Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes.</a> February 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21898757/'>Distribution and frequency of VKORC1 sequence variants conferring resistance to anticoagulants in Mus musculus.</a> May 12  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21895980/'>Genetic, clinical and behavioural determinants of vitamin K-antagonist dose--explored through multivariable modelling and visualization.</a> July 8  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21900891/'>Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22023024/'>The pharmacogenetics of the response to warfarin in Chinese.</a> June 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22040439/'>Extremely low warfarin dose in patients with genotypes of CYP2C9*3/*3 and VKORC1-1639A/A.</a> May 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22047153/'>Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.</a> May 30  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22114699/'>Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation.</a> May 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22120087/'>[Development of a single-tube PCR-pyrosequencing method for simultaneous and rapid detection of the genetic polymorphism of warfarin metabolizing enzymes].</a> January 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22118051/'>Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.</a> March 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22122181/'>Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.</a> March 31  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22173503/'>Decreased expression of vitamin K epoxide reductase complex subunit 1 in kidney of patients with calcium oxalate urolithiasis.</a> June 5  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22188360/'>Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU.</a> July 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22228255/'>Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.</a> May 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22252093/'>Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users.</a> September 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22266406/'>Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic.</a> June 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22274142/'>Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.</a> May 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22290467/'>Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants.</a> June 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22321278/'>[Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].</a> May 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22393834/'>Genetic polymorphisms of VKORC1, CYP2C9, CYP4F2 in Bai, Tibetan Chinese.</a> March 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22409277/'>An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol.</a> August 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22452429/'>Warfarin pharmacogenetics: polymorphisms of the CYP2C9, CYP4F2, and VKORC1 loci in a genetically admixed Omani population.</a> July 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22528326/'>Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.</a> November 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22528324/'>Genetic variations in stem cell-related genes and colorectal cancer prognosis.</a> June 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22528291/'>NMR structure note: human esophageal cancer-related gene 2.</a> September 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22534826/'>A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation.</a> October 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22534796/'>Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension.</a> November 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22534794/'>A two-stage matched case-control study on multiple hypertensive candidate genes in Han Chinese.</a> November 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22534784/'>Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22534782/'>Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22533669/'>Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.</a> February 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22571356/'>Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.</a> September 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22676711/'>Pharmacogenomics of warfarin in populations of African descent.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22676651/'>A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.</a> February 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22676585/'>Probing the Xenopus laevis inner ear transcriptome for biological function.</a> May 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22676574/'>Novel genetic linkage of rat Sp6 mutation to Amelogenesis imperfecta.</a> October 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22676552/'>Genome-wide characterization of Vibrio phage φpp2 with unique arrangements of the mob-like genes.</a> February 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22763922/'>Pharmacogenetic tests could be helpful in predicting of VKA maintenance dose in elderly patients at treatment initiation.</a> June 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22836303/'>Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation.</a> February 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22836289/'>The role of mutation status of the epidermal growth factor receptor gene in advanced non-small cell lung cancer.</a> January 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22855348/'>Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.</a> August 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22854539/'>Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.</a> April 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22854535/'>Adenosine induces apoptosis in SBC-3 human lung cancer cells through A(3) adenosine receptor-dependent AMID upregulation.</a> December 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22864379/'>VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.</a> August 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22863573/'>Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G&gt;A polymorphisms in a population from South-Eastern Europe.</a> February 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22871999/'>Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.</a> October 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22892446/'>Influence of CYP4F2 polymorphisms and plasma vitamin K levels on warfarin sensitivity in Japanese pediatric patients.</a> July 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22907842/'>Tailoring drug therapy based on genotype.</a> December 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22915323/'>VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.</a> March 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22915320/'>ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms.</a> June 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22917719/'>A multiplex assay to detect variations in the CYP2C9, VKORC1, CYP4F2 and APOE genes involved in acenocoumarol metabolism.</a> June 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22952875/'>Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.</a> February 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22990331/'>CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.</a> September 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23041981/'>Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.</a> June 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23041956/'>Prime time for molecular marker diagnostics in neuro-oncology.</a> May 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23041938/'>Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease.</a> October 18  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23041841/'>A novel disease-modifying osteoarthritis drug candidate targeting Runx1.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23041840/'>Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23041776/'>A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.</a> July 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23039877/'>VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity.</a> June 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23047901/'>[Vitamin K antagonists: from discovery to pharmacogenetics].</a> February 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23065265/'>The prevalence of VKORC1 1639 G&gt;A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.</a> April 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23061746/'>Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.</a> August 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23089672/'>Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.</a> October 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23104259/'>Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.</a> March 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23113310/'>CYP2C9 and VKORC1 gene polymorphism is inessential for bleeding development under conditions of oral application of anticoagulant acenocoumarol in Russian patients at high risk of thromboembolic complications.</a> April 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23124848/'>Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians.</a> March 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23132553/'>Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.</a> January 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23154637/'>miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle.</a> May 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23159639/'>The impact of the CYP2C9 and VKORC1 polymorphisms on acenocoumarol dose requirements in a Romanian population.</a> July 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23159229/'>The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment.</a> September 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23167228/'>The combined effects of clinical factors and CYP2C9 and VKORC1 gene polymorphisms on initiating warfarin treatment in patients after cardiac valve surgery.</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23183958/'>Genetic and clinical determinants influencing warfarin dosing in children with heart disease.</a> September 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23196355/'>Creating a genotype-based dosing algorithm for acenocoumarol steady dose.</a> June 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23201087/'>Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G&gt;A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients.</a> February 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24858991/'>The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk.</a> April 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23276529/'>Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.</a> October 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23279643/'>The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children.</a> August 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23285254/'>Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans.</a> July 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24858991/'>The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk.</a> April 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23362849/'>VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement.</a> August 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23436703/'>Gene-gene-environment interactions between drugs, transporters, receptors, and metabolizing enzymes: Statins, SLCO1B1, and CYP3A4 as an example.</a> March 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23481074/'>Cytochrome P450 (CYP2C9*2,*3) &amp; vitamin-K epoxide reductase complex (VKORC1 -1639G&lt;A) gene polymorphisms &amp; their effect on acenocoumarol dose in patients with mechanical heart valve replacement.</a> January 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23571513/'>VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians.</a> January 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23579966/'>Expanding role of pharmacogenomics in the management of cardiovascular disorders.</a> January 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23586031/'>Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia.</a> November 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23602689/'>Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian population.</a> January 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23602673/'>Enhancement of bone consolidation in mandibular distraction osteogenesis: a contemporary review of experimental studies involving adjuvant therapies.</a> August 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23686351/'>Pharmacogenetics and cardiovascular disease--implications for personalized medicine.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23691226/'>Novel associations of VKORC1 variants with higher acenocoumarol requirements.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23703341/'>Relationship between VKORC1 single nucleotide polymorphism 1173C&gt;T, bone mineral density &amp; carotid intima-media thickness.</a> January 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23726967/'>Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23732872/'>Association of VKORC1-1639G&gt;A polymorphism with susceptibility to ossification of the posterior longitudinal ligament of the spine: a Korean study.</a> April 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23774101/'>The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes.</a> March 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23771743/'>Influence of VKORC1 gene polymorphisms on the effect of oral vitamin K supplementation in over-anticoagulated patients.</a> February 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23781667/'>Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response.</a> September 27  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23806093/'>Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy.</a> April 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23907550/'>Effects of inflammatory cytokine gene polymorphisms on warfarin maintenance doses in Korean patients with mechanical cardiac valves.</a> January 27  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23928358/'>VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23954225/'>Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.</a> October 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23972066/'>Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G&gt;A gene polymorphism in patients with retinal vein occlusion.</a> June 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24088351/'>[Personalized drug therapy-directed clinical pharmacology research based on genetic polymorphisms and pharmacokinetics analysis].</a> April 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24224579/'>A new algorithm for weekly phenprocoumon dose variation in a southern Brazilian population: role for CYP2C9, CYP3A4/5 and VKORC1 genes polymorphisms.</a> October 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24288433/'>Association of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population.</a> July 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24288432/'>Association of a FGFR-4 gene polymorphism with bronchopulmonary dysplasia and neonatal respiratory distress.</a> July 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24287930/'>Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.</a> August 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24322971/'>Cardiovascular pharmacogenomics: expectations and practical benefits.</a> April 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24322967/'>HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.</a> October 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24337438/'>A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone.</a> April 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24350371/'>The patent bargain.</a> January 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24350348/'>FUS: a putative biomarker for essential tremor raised by whole-exome sequencing analyses.</a> May 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24350340/'>Reply to Coyne: Genomic analyses are unthwarted.</a> January 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24399734/'>Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.</a> August 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24425227/'>The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations.</a> April 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24425205/'>Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation.</a> October 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24474498/'>VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.</a> June 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24491178/'>Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling.</a> April 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24535562/'>Association between VKORC1 gene polymorphisms and ischemic cerebrovascular disease in Chinese Han population.</a> January 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24533715/'>Pharmacogenetics-based warfarin dosing in children.</a> October 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24533714/'>Intraindividual somatic variations in MTHFR gene polymorphisms in relation to colon cancer.</a> October 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24533713/'>CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.</a> October 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24533712/'>Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.</a> October 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24593903/'>Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24601977/'>The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.</a> August 1  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24636047/'>[Cardiovascular pharmacogenomics].</a> January 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24636043/'>The hidden activism of the misnamed.</a> January 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24660123/'>Does ethnicity play a role in the dosing of warfarin in Hawai'i?</a> April 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24762275/'>Genomics of bleeding disorders.</a> December 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24790995/'>A new nested allele-specific multiplex polymerase chain reaction method for haplotyping of VKORC1 gene to predict warfarin sensitivity.</a> January 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24797541/'>Frequency of CYP2C9 and VKORC1 gene polymorphisms and their influence on warfarin dose in Egyptian pediatric patients.</a> May 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24867283/'>Pharmacogenetics in Jewish populations.</a> July 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24867262/'>Potential biomarkers and latent pathways for vasculitis based on latent pathway identification analysis.</a> June 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24908449/'>VKORC1 and CYP2C9 genotype distribution in Asian countries.</a> May 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24911077/'>CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: influence on quality of long-term anticoagulation.</a> March 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24919870/'>Pharmacogenetics role in the safety of acenocoumarol therapy.</a> June 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24919868/'>The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses.</a> July 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24939302/'>Involvement of VKORC1 in the inhibition of calcium oxalate crystal formation in HK-2 cells.</a> October 1  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24942396/'>Patients benefit from genetics-guided coumarin anticoagulant therapy.</a> August 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956252/'>Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956244/'>Warfarin dose requirements in a patient with the CYP2C9*14 allele.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956226/'>Association study of childhood obesity with eight genetic variants recently identified by genome-wide association studies.</a> October 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956223/'>Genetic risk variants of schizophrenia associated with left superior temporal gyrus volume.</a> May 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24966969/'>High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24974237/'>Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke.</a> March 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24978953/'>VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.</a> October 19  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25069408/'>Multiplex pyrosequencing method to determine CYP2C9*3, VKORC1*2, and CYP4F2*3 polymorphisms simultaneously: its application to a Korean population and comparisons with other ethnic groups.</a> June 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25075423/'>Characterization of a novel CYP2C9 mutation (1009C&gt;A) detected in a warfarin-sensitive patient.</a> February 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25079360/'>Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25109798/'>The COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation?</a> June 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25117329/'>Pharmacogenomics: accessing important alleles by imputation from commercial genome-wide SNP arrays.</a> April 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25142093/'>Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study.</a> March 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25155935/'>Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.</a> May 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25181036/'>Is personalized medicine a dream or a reality?</a> September 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25187307/'>Effect of CYP2C9-VKORC1 interaction on warfarin stable dosage and its predictive algorithm.</a> January 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25264593/'>Efficiency of exome sequencing for the molecular diagnosis of pseudoxanthoma elasticum.</a> May 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25307756/'>Seven novel probe systems for real-time PCR provide absolute single-base discrimination, higher signaling, and generic components.</a> June 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25307752/'>Dietary influences on tissue concentrations of phytanic acid and AMACR expression in the benign human prostate.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25307738/'>Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).</a> January 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25312789/'>Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25318916/'>Frequencies of polymorphisms in CYP2C9 and VKORC1 genes influencing warfarin metabolism in Slovak population: implication for clinical practice.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25385663/'>Genes affecting warfarin response-interactive or additive?</a> April 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25419701/'>Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.</a> July 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25492821/'>[Effect of genetic variations on adjusting of warfarin dose].</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25560189/'>Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.</a> April 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25592578/'>Measures of exposure impact genetic association studies: an example in vitamin K levels and VKORC1.</a> April 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25699611/'>Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.</a> April 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25863101/'>[Association of VKORC1 gene -1639G/A polymorphism with atrial fibrillation in ethnic Uygurs and Hans from Xinjiang].</a> June 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25885753/'>Warfarin resistance due to VKORC1 gene mutation in a patient following mechanical aortic valve replacement with an ON-X valve.</a> April 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25904339/'>Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.</a> March 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25976278/'>VKORC1 -1639 G&gt;A Polymorphism in Romanian Patients With Deep Vein Thrombosis.</a> May 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26040031/'>[Association of allelic polymorphisms of genes matrix Gla-protein system with ischemic atherothrombotic stroke].</a> June 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26113018/'>Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes.</a> May 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26167638/'>VKORC1 -1639G/A and 1173 C/T Genetic Polymorphisms Influence Individual Differences in Warfarin Maintenance Dose.</a> July 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26219158/'>The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis.</a> August 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26267707/'>PGWD: Integrating Personal Genome for Warfarin Dosing.</a> October 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26264021/'>VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?</a> May 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26418980/'>[Influence of genetic polymorphisms and non-genetic factors on the maintenance dose of warfarin].</a> December 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26423926/'>Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.</a> February 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26422867/'>VKORC1 and CYP2C9 genotypic data-based dose prediction alone does not accurately predict warfarin dose requirements in some Malaysian patients.</a> October 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26433837/'>The influence of VKORC1 gene polymorphism on warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.</a> September 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26445138/'>VKORC1 gene polymorphisms and adverse events in Croatian patients on warfarin therapy.</a> December 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26505400/'>Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.</a> August 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26502504/'>[Comparison of Empiric and Pharmacogenetic Approaches in Assessment of Efficacy of Anticoagulant Therapy].</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26568290/'>A fully integrated and automated microsystem for rapid pharmacogenetic typing of multiple warfarin-related single-nucleotide polymorphisms.</a> September 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26583785/'>Effects of VKORC1 Genetic Polymorphisms on Warfarin Maintenance Dose Requirement in a Chinese Han Population.</a> October 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26600534/'>VKORC1 rs2359612 and rs9923231 polymorphisms correlate with high risks of cardiovascular and cerebrovascular diseases.</a> September 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26621101/'>Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.</a> October 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26632549/'>Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.</a> October 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26632531/'>Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.</a> October 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26632513/'>Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.</a> October 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26632512/'>Transplantation of VEGFl65-overexpressing vascular endothelial progenitor cells relieves endothelial injury after deep vein thrombectomy.</a> October 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26757860/'>[Effect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals].</a> May 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26781925/'>High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol.</a> May 6  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26802680/'>Human cell lines: A promising alternative for recombinant FIX production.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26870974/'>[FREQUENCY OF POLYMORPHISM OF VKORC1 AND CYP2C9 GENES IN TWO REGIONS OF GEORGIA].</a> October 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26870959/'>Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting.</a> July 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26870958/'>Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination.</a> June 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26940072/'>Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26939421/'>[HORMONAL-GENETIC SCREENING IN PATIENTS, SUFFERING GASTRODUODENAL ULCER HEMORRHAGE].</a> March 25  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26947514/'>Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.</a> June 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26995878/'>[Companion Diagnostics for Thrombotic Disease].</a> April 26  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27401392/'>[Effect of the -1639G &gt; A polymorphism of the VKORC1 gene on the dose of oral anticoagulants acenocoumarol, and warfarin in Chilean patients: alternative models of inheritance].</a> April 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27434945/'>[HORMONALLY-GENETICALLY DEPENDENT THERAPY, USING VITAMIN K IN PATIENTS, SUFFERING THE ULCER HEMORRHAGE].</a> August 3  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27636550/'>A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.</a> September 17  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27703968/'>G-1639A but Not C1173T VKORC1 Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population.</a> January 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27743182/'>Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.</a> October 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27743168/'>MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.</a> October 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27743162/'>miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6.</a> October 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27765905/'>Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.</a> October 22  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27824210/'>VKCFD2 - from clinical phenotype to molecular mechanism.</a> June 2  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27959270/'>Speculations on vitamin K, VKORC1 genotype and autism.</a> December 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28025970/'>Impact of VKORC1 gene polymorphisms on warfarin maintenance dosage: A novel systematic review and meta-analysis of 53 studies.</a> December 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28033245/'>VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.</a> February 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28032893/'>Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.</a> December 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28079798/'>Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement.</a> February 28  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28079792/'>Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.</a> February 28  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28079506/'>Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.</a> January 13  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28079488/'>Association analysis of ANK3 variants with bipolar disorder in the Korean population.</a> January 13  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28083852/'>DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation.</a> January 14  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28083843/'>MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.</a> January 14  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28083801/'>Unravelling the Lesser Known Facets of Angiotensin II Type 1 Receptor.</a> January 14  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28216623/'>Development of a novel individualized warfarin dose algorithm based on a population pharmacokinetic model with improved prediction accuracy for Chinese patients after heart valve replacement.</a> February 21  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28371488/'>Bioequivalence Study of Warfarin in Healthy Chinese Volunteers With a Validated High-Performance Liquid Chromatography-Mass Spectrometry Method.</a> April 4  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28388432/'>Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci.</a> April 8  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28620303/'>Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response.</a> June 18  2017<br></body></html>
